Viewing Study NCT01097460


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-27 @ 11:48 PM
Study NCT ID: NCT01097460
Status: COMPLETED
Last Update Posted: 2015-01-07
First Post: 2010-03-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Sponsor: Merrimack Pharmaceuticals
Organization: